NCT05922735View on ClinicalTrials.gov

Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users

UnknownOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions

Monkey PoxHIV Infections

Interventions

BEHAVIORAL

Questionnaire

Serology from remaining blood sample Self-questionnaire about sexual behavior during the epidemy mpox

Sponsors

Collaborators (1)

Institut Pasteur

All Listed Sponsors

collaborator

INSERM UMR S 1136

OTHER

collaborator

Institut de Recherche en Santé Publique, France

OTHER

collaborator

Institut Pasteur

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT05922735 - Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users | Biotech Hunter | Biotech Hunter